3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Recurrence
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Graft vs Host Disease
1
Burkitt Lymphoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Rituximab
13
Cyclophosphamide
9
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
venetoclax
6
obinutuzumab
5
ibrutinib
5
Specimen Handling
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Prednisone
4
CT-P10
4
Biopsy
4
zanubrutinib
3
orelabrutinib
3
Vincristine
3
Mycophenolic Acid
3
Cyclosporine
3
polatuzumab vedotin
2
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Doxorubicin
2
Busulfan
2
Bendamustine Hydrochloride
2
voruciclib
1
treosulfan
1
tafasitamab
1
prednylidene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Clofarabine
×
90 days
×
Clear all
No trials found.